Showing 101-110 of 3058 results for "".
Vagus Nerve Stimulation: Effects Beyond the Nervous System
https://practicalneurology.com/programs/practical-neurology/vagus-nerve-stimulation-effects-beyond-the-nervous-system/30101/Stavros Zanos, MD, PhD, Associate Professor, Institute of Bioelectronic Medicine, Feinstein Institutes for Medical Research, uses neurostimulation as a means to study the nervous system and to treat diseases in which the nervous system is affected or implicated. In this episode, Dr. Zanos gives an oProposed Hospital Standards for Parkinson Disease Care Aim to Avoid Preventable Harm
https://practicalneurology.com/programs/practical-neurology/proposed-hospital-standards-for-parkinson-disease-care-aim-to-avoid-preventable-harm/35438/Preventable harm is a serious concern for patients with Parkinson disease who receive care in the hospital setting, even when admitted for reasons other than their diagnosis. Peter Pronovost, MD, PhD, FCCM, Chief Quality and Transformation Officer at University Hospitals Cleveland Medical Center, ClNMOSD Part 1 - Overview and important considerations for diagnosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/nmosd-part-1-overview-and-important-considerations-for-diagnosis/30086/In this series, Derrick Robertson, MD, Director of the Multiple Sclerosis Division at the University of Southern Florida discusses multiple aspects of NMOSD. Dr. Robertson is talking with us today on behalf of Horizon Therapeutics which is compensating him for his services and is sponsoring this podDetecting Multiple Sclerosis Earlier: PRLs and the Evolving McDonald Diagnostic Criteria
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/detecting-multiple-sclerosis-earlier-prls-and-the-evolving-mcdonald-diagnostic-criteria/54390/This episode explores new evidence showing that paramagnetic rim lesions (PRLs) are highly prevalent early in multiple sclerosis (MS) and can differentiate MS from mimics with striking accuracy. Daniel Ontaneda, MD, PhD, Cleveland Clinic Lerner College of Medicine, Cleveland, OH, and Pascal Sati, PhMaturing with Migraine: Practical Guidelines for Transitioning Adolescent Migraine and Headache Patients into Adult Practice
https://practicalneurology.com/diseases-diagnoses/headache-pain/maturing-with-migraine-practical-guidelines-for-transitioning-adolescent-migraine-and-headache-patients-into-adult-practice/48903/Hope O’Brien, MD, MBA, FAHS, FAAN, Founder and CEO of the Headache Center of Hope, Cincinnati, OH, discusses challenges and considerations for adult headache neurologists who are onboarding adolescent patients as they transition from pediatric practice. Dr. O’Brien highlights a framework with strateNavigating Treatment Decisions for Individuals with Spinal Muscular Atrophy
https://practicalneurology.com/diseases-diagnoses/neuromuscular/navigating-treatment-decisions-for-individuals-with-spinal-muscular-atrophy/39222/Spinal muscular atrophy (SMA) care has shifted dramatically with the introduction of disease-modifying therapies, but how do clinicians weigh treatment options across different patient populations? In this episode of NeuroFrontiers, Charles Turck, PharmD, BCPS, BCCP, speaks with John Brandsema, MD aThe Consequences of Delays in the Diagnosis of Generalized Myasthenia Gravis
https://practicalneurology.com/diseases-diagnoses/neuromuscular/the-consequences-of-delays-in-the-diagnosis-of-generalized-myasthenia-gravis/39223/Delayed diagnosis of generalized myasthenia gravis is a common challenge, often leading to misdiagnosis, increased disease severity, and reduced quality of life. In this episode of NeuroFrontiers, John A. Morren, MD, FAAN, FAANEM discusses why diagnostic delays occur, how they impact patient outcomeUpdates from the American Headache Society: Diagnostic Criteria, Preventive CGRP Therapy, and Treatment Guidance
https://practicalneurology.com/diseases-diagnoses/headache-pain/updates-from-the-american-headache-society-diagnostic-criteria-preventive-cgrp-therapy-and-treatment-guidance/37873/Jessica Ailani, MD, FAHS, FAAN, FANA, Clinical Professor of Neurology at MedStar’s Georgetown University Hospital and Director of the MedStar Georgetown Headache Center, joins Charles Turck, PharmD, BCPS, BCCCP, President of ScientiaCME, to review essential American Headache Society updates for migrLiving with Spinal Muscular Atrophy: Genetic Testing, Therapy, and More
https://practicalneurology.com/case-reports/neuromuscular/living-with-spinal-muscular-atrophy-genetic-testing-therapy-and-more/54597/Andrew Cherico, a student at the University of Central Florida, Orlando, FL, discusses his experience living with spinal muscular atrophy (SMA), the impacts of available treatments, and how the condition intersects with his passion for sports journalism. He is joined by John W. Day, MD, PhD, ProfessWhen Migraine Treatments Fails: Navigating Therapy Switching
https://practicalneurology.com/diseases-diagnoses/headache-pain/when-migraine-treatments-fails-navigating-transitions-in-therapy/37870/What happens when first-line migraine therapies don’t deliver? Vincent Martin, MD, FACP, FAHS, Director of the Headache and Facial Pain Center at the Gardner Neuroscience Institute and Professor of Clinical Medicine in the Division of Internal Medicine at the University of Cincinnati, OH, joins Char